insights_auto
Why is AGIO up 2.66%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.95
arrow_upward
+2.66%(+0.88) 1D
$33.95
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 21, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$33.70
High
$34.14
Low
$33.30
Mkt. cap
2.03B
Avg. vol.
939.37K
Volume
884.55K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
Open
$33.70
High
$34.14
Low
$33.30
Mkt. cap
2.03B
Avg. vol.
939.37K
Volume
884.55K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc